Our Track Record

• 26 Projects started (24 in Heidelberg, 2 in New Haven)
• 70% Recurrent (18 out of 26)
• 14% CAGR of revenues in past 10 years
• 7 Startups seeded
• 12 Global Pharma Partners + 1 new starting on January 25
• Over 100 €M invested in early Innovation in past 12 Years